Recent reports have demonstrated that NEDD8 promotes tumor progression and predicts a poor prognosis in patients with colorectal cancer [6], nasopharyngeal carcinoma [7] and bladder cancer [8]. This evidence concerns the gene NEDD8 and neoplasm.